Latest Breaking News On - Core revenue growth - Page 1 : comparemela.com

Gates Industrial Reports Fourth-Quarter and Full Year 2023 Results

Gates Industrial Reports Fourth-Quarter and Full Year 2023 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesIvo jurekGates industrial corporation fourthGates industrial corporationSecurities exchangeBlackstone incExchange commissionNet incomeIndustrial corporationGates industrialChief executive officerPersonal mobilityDiversified industrialFirst fitPower transmissionTransmission adjusted

Neogen Announces Fourth-Quarter 2023 Results

Revenue of $241.8 million, an increase of 72.6% over the prior-year quarter.Net income of $5.6 million; $0.03 per diluted share.Adjusted Net Income of $30.2 million; $0.14 per diluted share.Adjusted.

Neogen corporationExchange commissionM food safety divisionCompany food safetySecurities exchangeM companyPrnewswire neogen corporationNeogen corporation fourth quarterNet incomeJohn adentChief executiveFood safety divisionFood safetyAnimal safetyBusiness highlightsAdjusted net income

Gates Industrial Reports First-Quarter 2023 Results

/PRNewswire/ First-Quarter 2023 Financial Summary Record first-quarter net sales of $897.7 million, up 0.5% compared to the prior-year period, including.

United statesIvo jurekGates industrial corporationBlackstone incSecurities exchangeGates industrial corporation firstExchange commissionNet incomeIndustrial corporationGates industrialChief executive officerAutomotive replacementPersonal mobilityEarnings per shareCash flowCore revenue growth

Gates Industrial Reports Fourth-Quarter and Full Year 2022 Results

/PRNewswire/ Fourth-Quarter 2022 Highlights Net sales of $893.3 million, representing 9.5% growth and core revenue growth of 16.0%. Net income attributable.

United statesIvo jurekExchange commissionBlackstone incSecurities exchangeGates industrial corporationGates industrial corporation fourth quarterNet incomeFree cash flowIndustrial corporationGates industrialChief executive officerFull year financialPersonal mobilityPower transmissionTransmission adjusted

Takeda Pharmaceutical Company Limited: Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions; Delivers Another Strong Quarter in FY2022 Q3

Announced Agreement With Nimbus Therapeutics in December to Acquire a Potential Best-in-Class TYK2 Inhibitor, and with HUTCHMED in January to In-license Highly Selective, Oral Tyrosine Kinase Inhibitor

United statesHong kongBrendan jenningsSchwierige zeitenChristopher oreillyInternational financial reporting standardsEuropean commissionArrowhead pharmaceuticals incExchange commissionChina national medical products administrationNimbus therapeuticsTakeda pharmaceutical company limitedConstant exchange rateAnnounced agreement with nimbus therapeuticsPotential best in classIn license highly selective